. . . . . "S&T TWOC Project - version 4" . "S&T TWOC version 3" . "2"^^ . "2023-07-20T09:47:15.732368"^^ . . . "for COVID-19 therapy" . "(306, 317)" . "considered" . "498" . "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone" . "(306, 317)" . "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." . "8j41d0a3" . "8j41d0a3-TRIPLE-ABSTRACT-2" . "teicoplanin" . "covid-19" . "RSA" . "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" . "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" . . .